购物车
全部删除
您的购物车当前为空
别名 奥司他韦杂质B(2-叠氮杂合物), Linazolamide intermediate B impurity 2, CPNQ, 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline
B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。

B2 (Linazolamide intermediate B impurity 2) 促进亨廷顿病和帕金森病细胞模型中的包涵体形成。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 278 | 现货 | |
| 5 mg | ¥ 583 | 现货 | |
| 10 mg | ¥ 826 | 现货 | |
| 25 mg | ¥ 1,370 | 现货 | |
| 50 mg | ¥ 2,020 | 现货 | |
| 100 mg | ¥ 2,730 | 现货 | |
| 200 mg | ¥ 3,770 | 现货 |
B2 相关产品
| 产品描述 | B2 (Linazolamide intermediate B impurity 2) promotes inclusion formation in cellular models of Huntington's disease and Parkinson's disease |
| 别名 | 奥司他韦杂质B(2-叠氮杂合物), Linazolamide intermediate B impurity 2, CPNQ, 5-[4-(4-Chlorobenzoyl)-1-piperazinyl]-8-nitroquinoline |
| 分子量 | 396.83 |
| 分子式 | C20H17ClN4O3 |
| CAS No. | 115687-05-3 |
| Smiles | [O-][N+](=O)c1ccc(N2CCN(CC2)C(=O)c2ccc(Cl)cc2)c2cccnc12 |
| 密度 | 1.412 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| 溶解度信息 | Ethanol: < 1 mg/mL (insoluble or slightly soluble) H2O: 2 mg/mL (5.04 mM), Sonication is recommended. DMSO: 50 mg/mL (126 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
评论内容